Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation.
Saved in:
| Title: | Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation. |
|---|---|
| Authors: | Frenel, J.-S.1 (AUTHOR) Jean-sebastien.frenel@ico.unicancer.fr, Lusque, A.2 (AUTHOR), Delaloge, S.3 (AUTHOR), Ferrero, J.-M.4 (AUTHOR), Bachelot, T.5 (AUTHOR), Desmoulins, I.6 (AUTHOR), Levy, C.7 (AUTHOR), Eymard, J.-C.8 (AUTHOR), Gonçalves, A.9 (AUTHOR), Patsouris, A.10 (AUTHOR), Reynier, M. A. Mouret11 (AUTHOR), Thery, M. J.-C.12 (AUTHOR), Petit, T.13 (AUTHOR), Cabel, L.14 (AUTHOR), Uwer, L.15 (AUTHOR), Debled, M.16 (AUTHOR), Chevrot, M.17 (AUTHOR), Mailliez, A.18 (AUTHOR), Jacot, W.19 (AUTHOR), de La Motte Rouge, T.20 (AUTHOR) |
| Source: | British Journal of Cancer. Jun2023, Vol. 128 Issue 11, p2072-2080. 9p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 163868789 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Frenel%2C+J%2E-S%2E%22">Frenel, J.-S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> Jean-sebastien.frenel@ico.unicancer.fr</i><br /><searchLink fieldCode="AR" term="%22Lusque%2C+A%2E%22">Lusque, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Delaloge%2C+S%2E%22">Delaloge, S.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ferrero%2C+J%2E-M%2E%22">Ferrero, J.-M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bachelot%2C+T%2E%22">Bachelot, T.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Desmoulins%2C+I%2E%22">Desmoulins, I.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Levy%2C+C%2E%22">Levy, C.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eymard%2C+J%2E-C%2E%22">Eymard, J.-C.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gonçalves%2C+A%2E%22">Gonçalves, A.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patsouris%2C+A%2E%22">Patsouris, A.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reynier%2C+M%2E+A%2E+Mouret%22">Reynier, M. A. Mouret</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thery%2C+M%2E+J%2E-C%2E%22">Thery, M. J.-C.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Petit%2C+T%2E%22">Petit, T.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cabel%2C+L%2E%22">Cabel, L.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Uwer%2C+L%2E%22">Uwer, L.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Debled%2C+M%2E%22">Debled, M.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chevrot%2C+M%2E%22">Chevrot, M.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mailliez%2C+A%2E%22">Mailliez, A.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jacot%2C+W%2E%22">Jacot, W.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+La+Motte+Rouge%2C+T%2E%22">de La Motte Rouge, T.</searchLink><relatesTo>20</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Cancer%22">British Journal of Cancer</searchLink>. Jun2023, Vol. 128 Issue 11, p2072-2080. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=163868789 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41416-023-02248-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 2072 Titles: – TitleFull: Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Frenel, J.-S. – PersonEntity: Name: NameFull: Lusque, A. – PersonEntity: Name: NameFull: Delaloge, S. – PersonEntity: Name: NameFull: Ferrero, J.-M. – PersonEntity: Name: NameFull: Bachelot, T. – PersonEntity: Name: NameFull: Desmoulins, I. – PersonEntity: Name: NameFull: Levy, C. – PersonEntity: Name: NameFull: Eymard, J.-C. – PersonEntity: Name: NameFull: Gonçalves, A. – PersonEntity: Name: NameFull: Patsouris, A. – PersonEntity: Name: NameFull: Reynier, M. A. Mouret – PersonEntity: Name: NameFull: Thery, M. J.-C. – PersonEntity: Name: NameFull: Petit, T. – PersonEntity: Name: NameFull: Cabel, L. – PersonEntity: Name: NameFull: Uwer, L. – PersonEntity: Name: NameFull: Debled, M. – PersonEntity: Name: NameFull: Chevrot, M. – PersonEntity: Name: NameFull: Mailliez, A. – PersonEntity: Name: NameFull: Jacot, W. – PersonEntity: Name: NameFull: de La Motte Rouge, T. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 00070920 Numbering: – Type: volume Value: 128 – Type: issue Value: 11 Titles: – TitleFull: British Journal of Cancer Type: main |
| ResultId | 1 |